Form 4 for TECH Bio-Techne
Accepted 2026-06-04 16:28:40 ET · period of report 2026-06-02 · accession 0000914190-26-000096 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-04 16:28 | 2026-06-02 | TECH | Crouse Steven C. | Pres - Diag, Spatial Bi | M - OptEx | — | +600 | 6,977 | +9% | — |
| D | 2026-06-04 16:28 | 2026-06-02 | TECH | Crouse Steven C. | Pres - Diag, Spatial Bi | F - Tax | $49.77 | -216 | 6,761 | -3% | -$10.8K |
| D | 2026-06-04 16:28 | 2026-06-02 | TECH | Crouse Steven C. | Pres - Diag, Spatial Bi | M - OptEx | $0.00 | -600 | 1,200 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-02 | M | A | 600 | — | 6,977 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F17) Due to a mathematical error on the Form 4 filed May 5, 2026, the number of shares beneficially owned is being increased by 40 shares and this filing represents the correct number of shares beneficially owned by the Reporting Person. |
| 2 | Common | Common Stock | 2026-06-02 | F | D | 216 | $49.77 | 6,761 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2026-06-02 | M | D | 600 | $0.00 | 1,200 | D | — · — to — | 600 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. (F3) 600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028. (F3) 600 restricted stock units vest on each of 6/2/2026, 6/2/2027 and 6/2/2028. |